Kim HG - Search Results

1

Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer.

Go SI, Park S, Kang MH, Kim HG, Kang JH, Kim JH, Lee GW. Go SI, et al. Among authors: kim hg, kim jh. Cancer Biomark. 2022;35(2):217-225. doi: 10.3233/CBM-220032. Cancer Biomark. 2022. PMID: 36120771

2

Combination chemotherapy with irinotecan and cisplatin in elderly patients (>or= 65 years) with extensive-disease small-cell lung cancer.

Kim HG, Lee GW, Kang JH, Kang MH, Hwang IG, Kim SH, Hahm JR, Jeong YY, Kim HC, Lee JD, Lee JS, Hwang YS. Kim HG, et al. Among authors: kim sh, kim hc. Lung Cancer. 2008 Aug;61(2):220-6. doi: 10.1016/j.lungcan.2007.12.020. Epub 2008 Feb 12. Lung Cancer. 2008. PMID: 18272249 Clinical Trial.

3

Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.

Kim KM, Kim HC, Jeon KN, Kim HG, Kang JH, Hahm JR, Lee GW. Kim KM, et al. Among authors: kim hg, kim hc. Yonsei Med J. 2008 Feb 29;49(1):155-8. doi: 10.3349/ymj.2008.49.1.155. Yonsei Med J. 2008. PMID: 18306483 Free PMC article.

4

Phase II trial of S-1 in combination with oxaliplatin in previously untreated patients with recurrent or inoperable biliary tract cancer.

Oh SY, Lee GW, Kim HG, Kim TH, Kim HJ, Kang JH. Oh SY, et al. Among authors: kim hg, kim hj, kim th. Chemotherapy. 2008;54(6):479-84. doi: 10.1159/000159624. Epub 2008 Oct 3. Chemotherapy. 2008. PMID: 18832821 Clinical Trial.

5

ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy.

Kim IS, Kim HG, Kim DC, Eom HS, Kong SY, Shin HJ, Hwang SH, Lee EY, Lee GW. Kim IS, et al. Among authors: kim hg, kim dc. Cancer Sci. 2008 Dec;99(12):2496-501. doi: 10.1111/j.1349-7006.2008.00985.x. Epub 2008 Nov 20. Cancer Sci. 2008. PMID: 19032367 Free article.

6

Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.

Lee GW, Kang MH, Kim HG, Kang JH, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim HJ, Lee JS. Lee GW, et al. Among authors: kim hg, kim hj, kim sh, kim hc. Cancer Chemother Pharmacol. 2009 Jul;64(2):385-90. doi: 10.1007/s00280-008-0885-5. Epub 2008 Dec 23. Cancer Chemother Pharmacol. 2009. PMID: 19104817

7

Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer.

Lee GW, Kim HJ, Ju JH, Kim SH, Kim HG, Kim TH, Kim HJ, Jeong CY, Kang JH. Lee GW, et al. Among authors: kim hg, kim hj, kim th, kim sh. Cancer Chemother Pharmacol. 2009 Sep;64(4):707-13. doi: 10.1007/s00280-008-0918-0. Epub 2009 Jan 17. Cancer Chemother Pharmacol. 2009. PMID: 19151975 Clinical Trial.

8

Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer.

Oh SY, Kim HJ, Kim TH, Lee GW, Kim HG, Jeong CY, Kwon HC, Kang JH. Oh SY, et al. Among authors: kim hg, kim hj, kim th. Invest New Drugs. 2010 Jun;28(3):343-9. doi: 10.1007/s10637-009-9265-1. Epub 2009 May 15. Invest New Drugs. 2010. PMID: 19444385 Clinical Trial.

9

Phase II study of a biweekly schedule of docetaxel and cisplatin in patients with metastatic non-small cell lung cancer.

Cho SH, Go SI, Lee GW, Kang JH, Kim HG, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS. Cho SH, et al. Among authors: kim hg, kim sh, kim hc. Lung Cancer. 2010 Jul;69(1):94-8. doi: 10.1016/j.lungcan.2009.09.005. Epub 2009 Sep 30. Lung Cancer. 2010. PMID: 19796840 Clinical Trial.

10

Is inactivation of O6-methylguanine DNA methyltransferase still a favorable prognostic factor of patients with diffuse large B-cell lymphoma in the era of R-CHOP chemotherapy?

Lee GW, Kang JH, Kim IS, Kim HG, Ko GH, Lee JH, Kim DC, Song DH, Yang JW, Lee JS. Lee GW, et al. Among authors: kim hg, kim dc, kim is. Leuk Lymphoma. 2009 Dec;50(12):1992-8. doi: 10.3109/10428190903312462. Leuk Lymphoma. 2009. PMID: 19860620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,921 results

Search Page